Skip to main content
Log in

Methoxamine inhibits noradrenaline release through activation of α1- and α2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The effects of the at-adrenoceptor agonist methoxamine and the α2-adrenoceptor agonist bromoxidine (UK 14034) on the stimulation induced (S-1) outflow of radioactivity at 100 Hz/6 pulses from rat isolated kidney preincubated with 3H-noradrenaline were investigated. Methoxamine (0.3 – 30 μmol/l) inhibited S-1 outflow of radioactivity to a maximum of 83% with a pEC50 of 5.85 (5.71–5.94). UK 14304 (0.0003-0.3 μmol/l) inhibited S-I outflow of radioactivity to a maximum of 99% with a pEC50 of 8.35 (8.26–8.47). a Adrenoceptor antagonist affinities (pKD) against methoxamine and UK 14304 at prejunctional α-adrenoceptors were determined. The concentration response curve of methoxamine was shifted to the right by the α1/α2B-adrenoceptor antagonist prazosin (0.1 μmol/l) with a pKD of 7.41 and that of UK 14304 by prazosin (0.3 μmol/l) with a pKD of 6.24. The α2-adrenoceptor antagonist rauwolscine (0.1 μmol/l) shifted the concentration response curve of UK 14304 potently to the right with a pKD of 8.34. The concentration response curve of methoxamine was shifted also to the right by rauwolscine (0.1 μmol/l) and the α2-adrenoceptor antagonist idazoxan (0.1 μmol/l), however, both antagonists suppressed the maximum response of methoxamine to 466% and 56%, respectively. A ten times lower concentration of rauwolscine (0.01 μmol/l) did not shift the concentration response curve of methoxamine but the inhibitory effect of methoxamine still reached only a maximum of 59%. The concentration response curve of methoxamine obtained in the presence of rauwolscine (0.01 μmol/l) was shifted to the right by further addition of prazosin (0.1 μmol/l) with a pKD of 8.80 but was also shifted to the right by either the purinoceptor antagonist 8-(p-sulfophenyl) theophylline (8-SPT; 100 μmol/l) or the prostaglandin synthesis inhibitor indomethacin (20 μmol/l). These results suggest that methoxamine inhibits S-1 outflow of radioactivity in rat isolated kidney probably through three different mechanisms. 1. Activation of postjunctional α1-adrenoceptors and prostaglandin mediated transjunctional inhibition. 2. Activation of postjunctional α2-adrenoceptors and purine mediated transjunctional inhibition. 3. Activation of prejunctional inhibitory α2-adrenoceptors at which methoxamine seems to be a partial agonist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58

    Google Scholar 

  • Blakeley AGH, Dunn PM, Peterson SA (1988) A study of the actions of P1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro. Br J Pharmacol 94:37–46

    Google Scholar 

  • Bohman C, Schollmeyer P, Rump LC (1993) α-Autoreceptor subclassification in rat isolated kidney using short trains of electrical stimulation. Br J Pharmacol 108:262–268

    Google Scholar 

  • Cooper CL, Malik KU (1985) Prostaglandin synthesis and renal vasoconstriction elicited by adrenergic stimuli are linked to activation of alpha-1 adrenergic receptors in the isolated rat kidney. J Pharmacol Exp Ther 233:24–31

    Google Scholar 

  • Fredholm BB, Hedqvist P (1978) Release of the 3H-purines from [3H]-adenine labelled rabbit kidney following sympathetic nerve stimulation and its inhibition by α-adrenoceptor blockade. Br J Pharmacol 64:239–245

    Google Scholar 

  • Fuder H, Bath F, Wiebelt H, Muscholl E (1984) Autoinhibition of nor-adrenaline release from the heart as a function of the biophase concentration of exogenous α-adrenoceptor agonists, cocaine and perfusion rate. Naunyn-Schmiedeberg's Arch Pharmacol 325:25–33

    Google Scholar 

  • Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines: Handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 283–335

    Google Scholar 

  • Göthert M, Schlicker E, Hentrich F, Rohm N, Zerkowski H-R (1984) Modulation of noradrenaline release in human saphenous vein via presynaptic α2-adrenoceptors. Eur J Pharmacol 102:261–267

    Google Scholar 

  • Göthert M, Molderings GJ (1991) Involvement of presynaptic imidazoline receptors in the ⇔ adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn-Schmiedeberg's Arch Pharmacol 343:271–282

    Google Scholar 

  • Guimaraes S, Paiva MQ, Moura D (1987) Alpha2-adrenoceptor-mediated responses to so-called selective alpha1-adrenoceptor agonists after partial blockade of alpha1-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 335:397–402

    Google Scholar 

  • Hedqvist P, Fredholm BB (1976) Effects of adenosine on adrenergic transmission: Prejunctional inhibition and postjunctional enhancements. Naunyn-Schmiedeberg's Arch Pharmacol 293:217–223

    Google Scholar 

  • Hedqvist P, Fredholm BB, Olundh S (1978) Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in rabbit kidney. Circulation Res 43:592–598

    Google Scholar 

  • Hentrich F, Göthert M, Greschuchna D (1986) Noradrenaline release in the human pulmonary artery is modulated by presynaptic α2-adrenoceptors. J Cardiovasc Pharmacol 8:539–544

    Google Scholar 

  • Hicks PE, Najar M, Vidal M, Langer SZ (1986) Possible involvement of presynaptic α1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR. Naunyn-Schmiedeberg's Arch Pharmacol 333:354–361

    Google Scholar 

  • Kahan T, Hjemdahl P (1987) Pre- and postjunctional α-adrenoceptor-meditated effects of prazosin, methoxamine and 6-fluoronoradrenaline in blood-perfused canine muscle in situ. Eur J Pharmacol 133:9–20

    Google Scholar 

  • Limberger N, Starke K (1983) Partial agonist effect of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline (RX 781094) at presynaptic α2-adrenoceptors in rabbit ear artery. Naunyn-Schmiedeberg's Arch Pharmacol 324:75–78

    Google Scholar 

  • Limberger N, Trendelenburg AU, Starke K (1992) Pharmacological characterization of presynaptic α2-autoreceptors in rat submaxillary gland and heart atrium. Br J Pharmacol 107:246–255

    Google Scholar 

  • Murphy TV, Majewski H (1989) Modulation of noradrenaline release in slices of rat kidney cortex through α,- and α2-adrenoceptors. Eur J Pharmacol 169:285–295

    Google Scholar 

  • Murphy TV, Majewski H (1990) Pertussis toxin differentiates between α,- and α2-adrenoceptors-mediated inhibition of noradrenaline release from rat kidney cortex. Eur J Pharmacol 169:285–295

    Google Scholar 

  • Paciorek PM, Shepperson NB (1985) Evidence for an indomethacin sensitive α1-adrenoceptor mediated modulation of responses in the pithed rat heart. Br J Pharmacol 84:40P

    Google Scholar 

  • Rist W, Schollmeyer P, Rump LC (1991) Relative importance of α -and α2-adrenoceptors for noradrenergic pressor responses in SHR (12–14 weeks) and WKY isolated kidneys. Naunyn-Schmiedeberg's Arch Pharmacol 344 [Suppl]:R130

    Google Scholar 

  • Rump LC, Bohmann C (1992) Evidence that sympathetic nerve endings of rat kidney possess α2-autoreceptors of the α2A-subtype. Br J Pharmacol 105 [Suppl]:60 p

  • Rump LC, Majewski H (1987a) Modulation of noradrenaline release through α1- and α2-adrenoceptors in rat isolated kidney. J Cardiovasc Pharmacol 9:500–507

    Google Scholar 

  • Rump LC, Majewski H (1987b) Methoxamine inhibits noradrenaline release in rat isolated kidney through release of prostaglandins and direct activation of inhibitory prejunctional α1-adrenoceptors. J Cardiovasc Pharmacol 10 [Suppl 4]:147–149

    Google Scholar 

  • Rump LC, Majewski H (1987c) Beta adrenoceptor facilitation of norepinephrine release is not dependent on local angiotensin II formation in the rat isolated kidney. J Pharmacol Exp Ther 243:1107–1112

    Google Scholar 

  • Rump LC, Schollmeyer P (1989) Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney. Br J Pharmacol 97:819–828

    Google Scholar 

  • Rump LC, Wolk V, Ruff G, Schollmeyer P (1992a) Activation of α1,and α2-adrenoceptors inhibits noradrenaline release in rabbit renal arteries: effects of pertussis toxin and N-ethylmalcimide. J Anton Pharmacol 12:97–108

    Google Scholar 

  • Rump LC, Wilde K, BohmannC, Schollmeyer P (1992b) Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney. Naunyn-Schmiedeberg's Arch Pharmacol 345:300–308

    Google Scholar 

  • Schmitz JM, Graham RM, Sagalowsky A, Pettinger WA (1981) Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations. J Pharmacol Exp Ther 219:400–406

    Google Scholar 

  • Schwartz DD, Malik KU (1990) Prazosin-sensitive prejunctional α2-adrenergic receptor modulates release of the adrenergic transmitter elicited by periarterial nerve stimulation in the rat kidney. Ann NY Acad Sci 604:639–642

    Google Scholar 

  • Schwartz DD, Malik KU (1992) Characterization of prejunctional alpha-2 adrenergic receptors involved in modulation of adrenergic transmitter release in the isolated perfused rat kidney. J Pharmacol Exp Ther 261:1050–1055

    Google Scholar 

  • Shinozuka K, Sedaa KO, Bjur RA, Westfall DP (1991) Participation by purines in the modulation of norepinephrine release by methoxamine. Eur J Pharmacol 192:431–434

    Google Scholar 

  • Smith K, Docherty JR (1992) Are the prejunctional α2-adrenoceptors of the rat vas deferens and submandibular gland of the α2A- or α2D-subtype? Eur J Pharmacol 219:203–210

    Google Scholar 

  • Starke K, Endo T, Taube HD (1975) Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78

    Google Scholar 

  • Starke K (1987) Presynaptic α-autoreceptors. Rev Physiol Biochem Pharmacol 107:73–146

    Google Scholar 

  • Story DF, Stanford-Starr CH, Rand MJ (1985) Evidence for the involvement of α1-adrenoceptors in negative feedback regulation of noradrenergic transmitter release in rat atria. Clin Sci 68 [Suppl 10]:111–115

    Google Scholar 

  • Uchida W, Kimura T, Satoh H (1984) Presence of presynaptic inhibitory α1-adrenoceptors in the cardiac sympathetic nerves of the dog: effects of prazosin and yohimbine on sympathetic neurotransmission to the heart. Eur J Pharmacol 103:51–56

    Google Scholar 

  • Valenta B, Drobny H, Singer ES (1988) Presynaptic autoinhibition of central noradrenaline release in vitro: opertional characteristics and effects at alpha-2 adrenoceptors in the presence of uptake inhibition. J Pharmacol Exp Ther 245:944–949

    Google Scholar 

  • Von Kilgelgen I, Späth L, Starke K (1992) Adenosine but not an adenine nucleotide mediates tonic purinergic inhibition, as well as inhibition by glutamate, of noradrenaline release in rabbit brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 346:677–684

    Google Scholar 

  • Waud DR (1975) Analysis of dose-response curves. In: Daniel EE, Paton DM (eds) Methods in pharmacology, vol 3. Plenum Press, New York London, pp 471–506

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to L. C. Rump at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bohmann, C., Schollmeyer, P. & Rump, L.C. Methoxamine inhibits noradrenaline release through activation of α1- and α2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins. Naunyn-Schmiedeberg's Arch Pharmacol 347, 273–279 (1993). https://doi.org/10.1007/BF00167445

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00167445

Key words

Navigation